tiprankstipranks
Establishment Labs Holdings Inc (ESTA)
NASDAQ:ESTA
Holding ESTA?
Track your performance easily

Establishment Labs Holdings (ESTA) Earnings Date & Reports

183 Followers

Earnings Data

Report Date
Mar 04, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
-$0.64
Last Year’s EPS
-$0.79
Same Quarter Last Year
Based on 6 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 07, 2024
|
% Change Since: -19.08%
|
Next Earnings Date:Mar 04, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong performance in the U.S. market following the FDA approval of Motiva Implants, alongside significant financial strengthening and cost reductions. However, challenges persist in Latin America and supply chain issues are present. Despite these challenges, the company is positioned for growth and profitability in 2025.
Company Guidance
During the third quarter of 2024, Establishment Labs reported a total revenue of $40.2 million, representing a 4.5% increase from the previous year. The company highlighted the successful U.S. launch of Motiva Implants, which began just two weeks after FDA approval on September 26. Over 250 accounts have been onboarded, with 70 already placing orders. Establishment Labs accessed $25 million from an existing credit facility and completed a $50 million equity raise, bringing their pro forma cash position to $114 million at the end of the quarter. The company also announced an EBITDA loss improvement to $7 million, down from over $16 million the prior year. Despite global demand pressures, particularly in Latin America, the company anticipates U.S. revenue to exceed $35 million in 2025, with the first positive EBITDA quarter expected that year.
FDA Approval and Successful U.S. Launch
The approval of Motiva Implants on September 26 was a significant milestone, with over 250 accounts onboarded and more than 70 placing orders within three weeks. The U.S. launch is expected to generate at least $35 million in revenue in 2025.
Financial Strengthening
Accessed $25 million under the existing credit facility and completed a $50 million equity raise. Pro forma cash position at the end of the third quarter was $114 million.
Significant Cost Reductions
Operating expenses reduced by approximately $19 million in the first nine months of 2024 compared to the previous year. SG&A expenses decreased by $5.9 million, and R&D expenses declined by $2.3 million year-over-year.
Mia Femtech Expansion
Offered in 29 cities globally with 78 certified plastic surgeons. The 3-year study showed no significant complications, indicating Mia's potential to expand in the breast aesthetics market.
Improved EBITDA Performance
EBITDA loss improved to $7 million this quarter from over $16 million last year. The company is on track to achieve positive EBITDA in 2025.
---

Establishment Labs Holdings (ESTA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ESTA Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 04, 20252024 (Q4)
-0.64 / -
-0.79
Nov 07, 20242024 (Q3)
-0.61 / -0.59
-1.1247.32% (+0.53)
Aug 06, 20242024 (Q2)
-0.51 / -0.62
-0.654.62% (+0.03)
May 08, 20242024 (Q1)
-0.67 / -0.58
-0.48-20.83% (-0.10)
Feb 28, 20242023 (Q4)
-0.91 / -0.79
-0.55-43.64% (-0.24)
Nov 07, 20232023 (Q3)
-0.80 / -1.12
-0.76-47.37% (-0.36)
Aug 08, 20232023 (Q2)
-0.72 / -0.65
-1.5257.24% (+0.87)
May 08, 20232023 (Q1)
-0.68 / -0.48
-0.24-100.00% (-0.24)
Feb 27, 20232022 (Q4)
-0.68 / -0.55
-0.596.78% (+0.04)
Nov 07, 20222022 (Q3)
-0.57 / -0.76
-0.61-24.59% (-0.15)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

ESTA Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 07, 2024$48.12$46.25-3.89%
Aug 06, 2024$36.53$35.56-2.66%
May 08, 2024$51.25$56.83+10.89%
Feb 28, 2024$38.46$45.68+18.77%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Establishment Labs Holdings Inc (ESTA) report earnings?
Establishment Labs Holdings Inc (ESTA) is schdueled to report earning on Mar 04, 2025, TBA Not Confirmed.
    What is Establishment Labs Holdings Inc (ESTA) earnings time?
    Establishment Labs Holdings Inc (ESTA) earnings time is at Mar 04, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ESTA EPS forecast?
          ESTA EPS forecast for the fiscal quarter 2024 (Q4) is -$0.64.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis